Epidemiological and Cytogenetic Study of the Bioresonance Effect on Human System

An attempt to examine bioresonance against epidemiological data from Greek laboratories and medical centres, combined with laboratory work using sister chromatid exchange. Melphalan and irinotecan serve as the genotoxic agents, testing whether the method offers cells any protection against harmful factors.

Practitioner Library Membership Required

You must be a Practitioner Library member to access this content.

Join Now

Already a member? Log in here
author avatar
David Franklin
David Franklin is an advocate of Bioresonance therapy. He has seen how this form of treatment has helped his wife Sarah, who suffers from Addisons disease. David supplies Bicom Optima devices to therapists all over the world, and he also trains them on how to use the medical equipment effectively.
Chat on WhatsAppUsually replies during business hours